Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01070602
Other study ID # SRIFIS-001
Secondary ID
Status Recruiting
Phase N/A
First received February 17, 2010
Last updated June 27, 2013
Start date July 2010
Est. completion date March 2014

Study information

Verified date March 2013
Source Meir Medical Center
Contact n/a
Is FDA regulated No
Health authority Israel: Ethics Commission
Study type Interventional

Clinical Trial Summary

Intraoperative Floppy Iris Syndrome (IFIS) may occur during cataract surgeries in patients treated with alpha 1 blockers. IFIS related to alpha 1 blocker Tamsulosin (used for prostate hypertrophy) was reported in 50-90% of patients. IFIS during surgery make the surgery more difficult and raise complication rate.

Using anterior corneal incisions was reported briefly in literature as a prophylactic means but was not studied prospectively. we believe (according to our clinical experience) that these anterior incisions do help to reduce the incidence and severity of IFIS signs and complications rate during surgeries.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date March 2014
Est. primary completion date December 2013
Accepts healthy volunteers No
Gender Both
Age group 55 Years and older
Eligibility Inclusion Criteria:

1. cataract candidates treated (in the present or in the past) with tamsulosin

2. aged 55 or more

3. candidates for topical anesthesia

4. no allergy to anticholinergic or adrenergic drugs

5. able to understand and sign an informed consent

Exclusion Criteria:

1. history of uveitis

2. iris neovascularization

3. s/p iris surgery

4. traumatic/uveitis induced cataract

5. dialysis / abscence of zonules

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Intraoperative Floppy Iris Syndrome

Intervention

Procedure:
anterior (more central) corneal paracentesis incision
3 corneal paracentesis incisions will be located 1 mm anterior to the limbus.

Locations

Country Name City State
Israel Meir Medical Center Kfar-Saba

Sponsors (1)

Lead Sponsor Collaborator
Meir Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary the number of IFIS cases observed during operation. during the operations Yes
Secondary assessing the clinical grade of observed IFIS cases during the operations Yes
See also
  Status Clinical Trial Phase
Completed NCT01693575 - Use of APX 100 Device for Small-pupil Cataract Surgery and Intraoperative Floppy-iris Syndrome N/A
Completed NCT06266962 - Comparing the Efficiency of Two Approaches in Patients at Risk of Developing Intraoperative Floppy Iris Syndrome Phase 4
Completed NCT03760185 - Pupil Dilation for Treatment of IFIS Phase 2
Completed NCT01704014 - Intraoperative Floppy Iris Syndrome in Korean Patients Taking α1-Adrenergic Receptor Antagonists N/A
Terminated NCT02093689 - Intraoperative Floppy Iris Syndrome Undergoing Intraocular Lens Replacement Surgery Phase 3
Terminated NCT00627913 - Retrobulbar Injection of Anesthesia Versus Healon 5 in the Management of Intraoperative Floppy Iris Syndrome N/A